1,185
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study

, &
Pages 5128-5137 | Received 03 Jun 2020, Accepted 18 Dec 2020, Published online: 31 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tarik Corbo, Abdurahim Kalajdzic, Dzenita Omerkic, Farah Catic, Naris Pojskic & Kasim Bajrovic. (2023) Inhibitory potential of phytochemicals on five SARS-CoV-2 proteins: in silico evaluation of endemic plants of Bosnia and Herzegovina. Biotechnology & Biotechnological Equipment 37:1.
Read now
Amit Singh & Abha Mishra. (2023) Molecular modelling study to discover novel JAK2 signaling pathway inhibitor. Journal of Biomolecular Structure and Dynamics 41:12, pages 5827-5838.
Read now

Articles from other publishers (2)

Abha Mishra & Amit Singh. (2022) Discovery of Histone Deacetylase Inhibitor Using Molecular Modeling and Free Energy Calculations. ACS Omega 7:22, pages 18786-18794.
Crossref
Aliyu Muhammad, Gilead Ebiegberi Forcados, Hadiza Sani, Uche Samuel Ndidi, Auwal Adamu, Babangida Sanusi Katsayal, Idris Zubairu Sadiq, Yakubu Saddeeq Abubakar, Ibrahim Sulaiman, Ibrahim Babangida Abubakar, Abdurrahman Pharmacy Yusuf, Ibrahim Malami, Sani Ibrahim & Murtala Bello Abubakar. (2022) Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID‐19. Journal of Food Biochemistry 46:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.